Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Oct 26, 2017	Harvard Bioscience Reports Third Quarter 2017 Financial Results HOLLISTON, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and nine months ended September 30, 2017.	View HTML Harvard Bioscience Reports Third Quarter 2017 Financial Results 67.7 KB
Toggle Summary Oct 25, 2017	Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors HOLLISTON, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed Katherine Eade and Thomas Loewald as Class II directors of the Board of	View HTML Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors 13.1 KB
Toggle Summary Oct 18, 2017	Harvard Bioscience Schedules Third Quarter 2017 Conference Call for October 26 at 4:30 PM ET HOLLISTON, Mass., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2017 after market trading hours on Thursday, October 26, 2017.	View HTML Harvard Bioscience Schedules Third Quarter 2017 Conference Call for October 26 at 4:30 PM ET 13.5 KB
Toggle Summary Jul 27, 2017	Harvard Bioscience Reports Second Quarter 2017 Financial Results HOLLISTON, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and six months ended June 30, 2017.	View HTML Harvard Bioscience Reports Second Quarter 2017 Financial Results 68.1 KB
Toggle Summary Jul 18, 2017	Harvard Bioscience Schedules Second Quarter 2017 Conference Call for July 27 at 4:30 PM ET HOLLISTON, Mass., July 18, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2017 after market trading hours on Thursday, July 27, 2017.	View HTML Harvard Bioscience Schedules Second Quarter 2017 Conference Call for July 27 at 4:30 PM ET 13.4 KB
Toggle Summary Jun 7, 2017	Harvard Bioscience Elects James Green as Chairman of Board of Directors HOLLISTON, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has elected James Green, a current Board member, as the new Chairman of its Board of	View HTML Harvard Bioscience Elects James Green as Chairman of Board of Directors 13.5 KB
Toggle Summary Apr 27, 2017	Harvard Bioscience Reports First Quarter 2017 Financial Results HOLLISTON, Mass., April 27, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported its financial results for the quarter ended March 31, 2017.	View HTML Harvard Bioscience Reports First Quarter 2017 Financial Results 52.2 KB
Toggle Summary Apr 19, 2017	Harvard Bioscience Schedules First Quarter 2017 Conference Call for April 27 at 4:30 PM ET HOLLISTON, Mass., April 19, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2017 after market trading hours on Thursday, April 27, 2017.	View HTML Harvard Bioscience Schedules First Quarter 2017 Conference Call for April 27 at 4:30 PM ET 13.4 KB
Toggle Summary Mar 9, 2017	Harvard Bioscience Reports Fourth Quarter and Year-End 2016 Results and 2017 Financial Guidance HOLLISTON, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported its financial results for the fourth quarter and full year ended December 31,	View HTML Harvard Bioscience Reports Fourth Quarter and Year-End 2016 Results and 2017 Financial Guidance 73.9 KB
Toggle Summary Feb 23, 2017	Harvard Bioscience Schedules Fourth Quarter 2016 Conference Call for March 9 at 4:30 PM ET HOLLISTON, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its fourth quarter 2016 after market trading hours on Thursday, March 9, 2017.	View HTML Harvard Bioscience Schedules Fourth Quarter 2016 Conference Call for March 9 at 4:30 PM ET 13.6 KB